Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
2.380
+0.100 (4.39%)
At close: Apr 25, 2025, 4:00 PM
2.370
-0.010 (-0.42%)
After-hours: Apr 25, 2025, 6:42 PM EDT

Akebia Therapeutics Market Cap

Akebia Therapeutics has a market cap or net worth of $621.73 million as of April 25, 2025. Its market cap has increased by 92.84% in one year.

Market Cap
621.73M
Enterprise Value
758.59M
1-Year Change
92.84%
Ranking
Category
Stock Price
$2.38

Market Cap Chart

Since March 20, 2014, Akebia Therapeutics's market cap has increased from $488.10M to $621.73M, an increase of 27.38%. That is a compound annual growth rate of 2.20%.

History

DateMarket Cap% Change
Apr 24, 2025538.60M29.94%
Dec 31, 2024414.50M77.44%
Dec 29, 2023233.60M120.17%
Dec 30, 2022106.10M-73.17%
Dec 31, 2021395.40M-2.30%
Dec 31, 2020404.70M-46.16%
Dec 31, 2019751.70M138.26%
Dec 31, 2018315.50M-55.11%
Dec 29, 2017702.90M76.17%
Dec 30, 2016399.00M0.81%
Dec 31, 2015395.80M67.15%
Dec 31, 2014236.80M-51.49%
View and export this data all the way back to 2014. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 765.09B
UnitedHealth Group 387.89B
Johnson & Johnson 372.44B
AbbVie 317.23B
Novo Nordisk 276.62B
Abbott Laboratories 224.54B
AstraZeneca 213.42B
Novartis AG 208.99B
Market Cap Rankings